The Duke Hematology-Oncology Fellowship program provides clinical, translational, and basic laboratory training in hematology, medical oncology, cell therapy and bone marrow transplantation. Program resources include more than 100 full-time faculty in the Divisions of Medical Oncology, Hematological Malignancies and Cellular Therapy, and Hematology. The Fellowship has an average of 21 fellows in different stages of training.
- Train future leaders in the fields of hematology and medical oncology
- Provide outstanding clinical training in all areas of hematology and medical oncology while maintaining compliance with policies and procedures of the ACGME and ABIM; and
- Instill lifelong passions for patient care and a vigorous pursuit of new knowledge through basic, translational and clinical research.
- Duke Cancer Institute treats more than 6,000 new cancer patients each year and is consistently recognized as the top cancer hospital in the southeast.
- Outstanding opportunities for multidisciplinary bench to bedside research can be found within the Duke Center for Genomic and Computational Biology, the Duke Cancer Care Research Program, the Duke Molecular Physiology Institute, the Duke Clinical & Translational Science Institute, the Department of Pharmacology and Cancer Biology, Center for the Study of Aging and Human Development, the Duke Sickle Cell Center and the Hemostasis and Thrombosis Center and the Duke Forge for machine learning in health science data.
Gowthami M. Arepally, MD
Associate Program Director, Hematology-Oncology Fellowship
Professor of Medicine and Pathology
Division of Hematology
Duke University Medical Center
Program Coordinator, Hematology-Oncology Fellowship
The Duke Department of Medicine (DOM) has long been at the forefront of advancing medical knowledge and fostering collaboration through its Continuing Medical Education (CME) efforts.
Dr. Caroline Sloan's passion for advocacy sparked during her residency at Duke.